Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Influenza

Flu season is coming for Europe. How bad could it be this year?

It’s difficult to say just how severe the flu season will be before it starts. Here’s how experts try to predict it.

Euronews

Avian influenza prevention zone to be introduced in NI

It will place a legal requirement on all bird keepers in the region to follow strict biosecurity measures.

Evening Standard

Bird flu prevention zone to be introduced in Northern Ireland

It will place a legal requirement on all bird keepers to follow strict biosecurity measures

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Record-high flu season as jab rates stall, GPs warn

Stalling vaccination rates among children and seniors are exacerbating a record-breaking flu season, the peak body for general practitioners says.

AAP

Is COVID Back? Mystery Flu Outbreak in Asia Sparks Panic, Experts Reveal the Disturbing Truth

A surge in flu cases across Asia, hitting Japan weeks early, has sparked global alarm. Experts warn this unpredictable, year-round spread could be the new normal.

International Business Times UK

Cidara Therapeutics Analyst Says Lead Influenza Candidate Is 'Strategically Attractive'

JP Morgan initiated coverage of Cidara Therapeutics Inc. (NASDAQ:CDTX) on Friday, citing its lead asset, CD388, for influenza, underscoring the game-changing potential of the product and multi-billion dollar potential in the U.S. alone.

Benzinga

Cidara Therapeutics Surges Ahead of ESWI 2025 Presentation and JP Morgan Coverage

Cidara Therapeutics Inc (NASDAQ:CDTX) shares are trading higher on Friday after the biotech company made a recent announcement about their presentation at the upcoming ESWI 2025 conference. JP Morgan also initiated coverage of the stock, assigning it an Overweight rating and setting a price target of $200.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Flu season has arrived – and so have updated flu vaccines

As the autumn’s cool weather settles in, so does flu season – bringing with it the familiar experiences of sniffles, fever and cough.

The Conversation

Cidara Shares Are Trading Higher Friday: What's Going On?

Cidara Therapeutics, Inc. (NASDAQ:CDTX) shares are trading higher Friday after the company secured $339 million in BARDA funding to advance its CD388 pandemic influenza therapeutic and onshore its manufacturing.

Benzinga

'We have basically destroyed what capacity we had to respond to a pandemic,' says leading epidemiologist Michael Osterholm

Live Science spoke with leading epidemiologist Michael Osterholm about his new book, "The Big One," which discusses the next pandemic and how to mitigate its harm.

LiveScience

Saving the world’s fattest parrot: can we vaccinate our rarest species before bird flu gets to them?

Trial in only continent untouched by avian flu suggests jabs will be key to survival as migration season approaches

The Guardian - UK

Denmark is in the midst of a ‘very unusual’ flu outbreak. A music festival is the culprit

Influenza typically causes outbreaks in the winter months in Denmark.

Euronews

Is it too late to get a flu shot?

It’s almost spring. And while respiratory infections seem to have passed their peak many people are still getting sick.

The Conversation

Common chocolate ingredient could be potent flu treatment, scientists find

Combination drug treatment outperformed most commonly used flu medicine Tamiflu, researchers say

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - AU

Six-year-old girl dies of influenza after twice being discharged from Sydney hospital

Girl was sent home from Sydney Children’s hospital in Randwick twice before being admitted to Northern Beaches hospital a day later, where she died

Reason

RFK Jr. Shifts $500 Million From mRNA Research to 'Safer' Vaccines. Do the Data Back That Up?

The Health and Human Services secretary once again stands athwart biomedical progress yelling, "Stop!"

The Guardian - UK

Despite RFK’s funding block, mRNA vaccines are too impressive to ignore

Scientists fear decision may increase vaccine hesitancy, but other countries are still willing to invest in research

The Conversation

Long-COVID, viruses and ‘zombie’ cells: new research looks for links to chronic fatigue and brain fog

Millions of people who recover from infections like COVID-19, influenza and glandular fever are affected by long-lasting symptoms. These include chronic fatigue, brain fog, exercise intolerance, dizziness, muscle or joint pain and gut problems. And many of these symptoms worsen after exercise, a phenomenon known as post-exertional malaise.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Novavax Shares Promising Results For Bird Flu Vaccine, Tested In Primates

Novavax, Inc. (NASDAQ:NVAX) on Thursday revealed preclinical data from the H5N1 avian pandemic influenza vaccine candidate.

Benzinga

What's Going On With Moderna Stock Wednesday?

Moderna Inc.’s (NASDAQ:MRNA) stock has surged approximately 37% in the last month but has dipped around 15% year to date.

The Conversation

COVID, flu, RSV: how these common viruses are tracking this winter – and how to protect yourself

Winter is here, and with it come higher rates of respiratory illnesses. If you’ve been struck down recently with a sore throat, runny nose and a cough, or perhaps even a fever, you’re not alone.

The Independent UK

Child hospitalised abroad as bird flu cases climb

Cambodia’s Ministry of Health recently confirmed the country’s twelfth human case of H5N1 avian influenza so far this year

The Conversation

Child hospitalised as bird flu cases climb in Cambodia

Cambodia’s Ministry of Health recently confirmed the country’s twelfth human case of H5N1 avian influenza so far this year. The patient, a five-year-old boy from Kampot province, is currently in intensive care with severe respiratory symptoms.

Al Jazeera

What is Thimerosal, vaccine preservative called ‘toxic’ by US health chief?

The mercury-based preservative was removed from most vaccines in 2001. Should it still be a concern today?

Latin Times

RFK Jr's New Advisory Panel Votes Against Vaccine Preservative Following Pitch From Ex-President of RFK Jr's Anti-Vaxx Org

A vaccine panel appointed by Health Secretary Robert F. Kennedy Jr. voted against recommending influenza vaccinations containing the preservative thimerosal, an agent that Kennedy himself and many anti-vaccination activists have long advocated against.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.